US authorizes Merck’s at-home antiviral COVID-19 pill
Published
Published
The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the..
Merck's drug molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30%.